Global Oncology Small Molecule Drugs Market 2019 by Company, Regions, Type and Application, Forecast to 2024

Table of Contents

1 Oncology Small Molecule Drugs Market Overview

• 1.1 Product Overview and Scope of Oncology Small Molecule Drugs
• 1.2 Classification of Oncology Small Molecule Drugs by Types
  • 1.2.1 Global Oncology Small Molecule Drugs Revenue Comparison by Types (2019-2024)
  • 1.2.2 Global Oncology Small Molecule Drugs Revenue Market Share by Types in 2018
  • 1.2.3 Chemotherapy Drugs
  • 1.2.4 Immunomodulating Drugs
  • 1.2.5 Targeted Therapy Drugs
  • 1.2.6 Hormonal Therapy
  • 1.2.7 Other
• 1.3 Global Oncology Small Molecule Drugs Market by Application
  • 1.3.1 Global Oncology Small Molecule Drugs Market Size and Market Share Comparison by Applications (2014-2024)
  • 1.3.2 Blood Cancer
  • 1.3.3 Breast Cancer
  • 1.3.4 Gastrointestinal Cancer
  • 1.3.5 Prostate Cancer
  • 1.3.6 Lung Cancer
  • 1.3.7 Other
• 1.4 Global Oncology Small Molecule Drugs Market by Regions
  • 1.4.1 Global Oncology Small Molecule Drugs Market Size (Million USD) Comparison by Regions (2014-2024)
  • 1.4.1 North America (USA, Canada and Mexico) Oncology Small Molecule Drugs Status and Prospect (2014-2024)
  • 1.4.2 Europe (Germany, France, UK, Russia and Italy) Oncology Small Molecule Drugs Status and Prospect (2014-2024)
  • 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Oncology Small Molecule Drugs Status and Prospect (2014-2024)
  • 1.4.4 South America (Brazil, Argentina, Colombia) Oncology Small Molecule Drugs Status and Prospect (2014-2024)
  • 1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Oncology Small Molecule Drugs Status and Prospect (2014-2024)
• 1.5 Global Market Size of Oncology Small Molecule Drugs (2014-2024)

2 Company Profiles

• 2.1 Johnson & Johnson
  • 2.1.1 Business Overview
  • 2.1.2 Oncology Small Molecule Drugs Type and Applications
    • 2.1.2.1 Product A
    • 2.1.2.2 Product B
  • 2.1.3 Johnson & Johnson Oncology Small Molecule Drugs Revenue, Gross Margin and Market Share (2017-2018)
• 2.2 AbbVie
  • 2.2.1 Business Overview
  • 2.2.2 Oncology Small Molecule Drugs Type and Applications
    • 2.2.2.1 Product A
    • 2.2.2.2 Product B
  • 2.2.3 AbbVie Oncology Small Molecule Drugs Revenue, Gross Margin and Market Share (2017-2018)
• 2.3 Celgene
  • 2.3.1 Business Overview
  • 2.3.2 Oncology Small Molecule Drugs Type and Applications
    • 2.3.2.1 Product A
    • 2.3.2.2 Product B
  • 2.3.3 Celgene Oncology Small Molecule Drugs Revenue, Gross Margin and Market Share (2017-2018)
• 2.4 Novartis
  • 2.4.1 Business Overview
  • 2.4.2 Oncology Small Molecule Drugs Type and Applications
    • 2.4.2.1 Product A
    • 2.4.2.2 Product B
  • 2.4.3 Novartis Oncology Small Molecule Drugs Revenue, Gross Margin and Market Share (2017-2018)
• 2.5 Roche
  • 2.5.1 Business Overview
  • 2.5.2 Oncology Small Molecule Drugs Type and Applications
    • 2.5.2.1 Product A
    • 2.5.2.2 Product B
  • 2.5.3 Roche Oncology Small Molecule Drugs Revenue, Gross Margin and Market Share (2017-2018)
• 2.6 Pfizer
  • 2.6.1 Business Overview
  • 2.6.2 Oncology Small Molecule Drugs Type and Applications
    • 2.6.2.1 Product A
    • 2.6.2.2 Product B
  • 2.6.3 Pfizer Oncology Small Molecule Drugs Revenue, Gross Margin and Market Share (2017-2018)
• 2.7 Takeda
  • 2.7.1 Business Overview
  • 2.7.2 Oncology Small Molecule Drugs Type and Applications
    • 2.7.2.1 Product A
    • 2.7.2.2 Product B
  • 2.7.3 Takeda Oncology Small Molecule Drugs Revenue, Gross Margin and Market Share (2017-2018)
• 2.8 Amgen
  • 2.8.1 Business Overview
  • 2.8.2 Oncology Small Molecule Drugs Type and Applications
    • 2.8.2.1 Product A
    • 2.8.2.2 Product B
  • 2.8.3 Amgen Oncology Small Molecule Drugs Revenue, Gross Margin and Market Share (2017-2018)
• 2.9 Bristol-Myers Squibb
  • 2.9.1 Business Overview
  • 2.9.2 Oncology Small Molecule Drugs Type and Applications
    • 2.9.2.1 Product A
    • 2.9.2.2 Product B
  • 2.9.3 Bristol-Myers Squibb Oncology Small Molecule Drugs Revenue, Gross Margin and Market Share (2017-2018)
• 2.10 Sanofi
  • 2.10.1 Business Overview
  • 2.10.2 Oncology Small Molecule Drugs Type and Applications
    • 2.10.2.1 Product A
    • 2.10.2.2 Product B
  • 2.10.3 Sanofi Oncology Small Molecule Drugs Revenue, Gross Margin and Market Share (2017-2018)
• 2.11 Merck
  • 2.11.1 Business Overview
  • 2.11.2 Oncology Small Molecule Drugs Type and Applications
    • 2.11.2.1 Product A
    • 2.11.2.2 Product B
  • 2.11.3 Merck Oncology Small Molecule Drugs Revenue, Gross Margin and Market Share (2017-2018)
• 2.12 Teva
  • 2.12.1 Business Overview
  • 2.12.2 Oncology Small Molecule Drugs Type and Applications
    • 2.12.2.1 Product A
    • 2.12.2.2 Product B
  • 2.12.3 Teva Oncology Small Molecule Drugs Revenue, Gross Margin and Market Share (2017-2018)
• 2.13 Eli Lilly
  • 2.13.1 Business Overview
  • 2.13.2 Oncology Small Molecule Drugs Type and Applications
    • 2.13.2.1 Product A
    • 2.13.2.2 Product B
  • 2.13.3 Eli Lilly Oncology Small Molecule Drugs Revenue, Gross Margin and Market Share (2017-2018)
• 2.14 Ipsen
  • 2.14.1 Business Overview
  • 2.14.2 Oncology Small Molecule Drugs Type and Applications
    • 2.14.2.1 Product A
    • 2.14.2.2 Product B
  • 2.14.3 Ipsen Oncology Small Molecule Drugs Revenue, Gross Margin and Market Share (2017-2018)
• 2.15 Biogen Idec
  • 2.15.1 Business Overview
  • 2.15.2 Oncology Small Molecule Drugs Type and Applications
    • 2.15.2.1 Product A
    • 2.15.2.2 Product B
  • 2.15.3 Biogen Idec Oncology Small Molecule Drugs Revenue, Gross Margin and Market Share (2017-2018)
• 2.16 Astellas
  • 2.16.1 Business Overview
  • 2.16.2 Oncology Small Molecule Drugs Type and Applications
    • 2.16.2.1 Product A
    • 2.16.2.2 Product B
  • 2.16.3 Astellas Oncology Small Molecule Drugs Revenue, Gross Margin and Market Share (2017-2018)
• 2.17 Bayer
  • 2.17.1 Business Overview
  • 2.17.2 Oncology Small Molecule Drugs Type and Applications
    • 2.17.2.1 Product A
    • 2.17.2.2 Product B
  • 2.17.3 Bayer Oncology Small Molecule Drugs Revenue, Gross Margin and Market Share (2017-2018)
• 2.18 Otsuka
  • 2.18.1 Business Overview
  • 2.18.2 Oncology Small Molecule Drugs Type and Applications
    • 2.18.2.1 Product A
    • 2.18.2.2 Product B
  • 2.18.3 Otsuka Oncology Small Molecule Drugs Revenue, Gross Margin and Market Share (2017-2018)
• 2.19 Eisai
  • 2.19.1 Business Overview
  • 2.19.2 Oncology Small Molecule Drugs Type and Applications
    • 2.19.2.1 Product A
    • 2.19.2.2 Product B
  • 2.19.3 Eisai Oncology Small Molecule Drugs Revenue, Gross Margin and Market Share (2017-2018)
• 2.20 AstraZeneca
  • 2.20.1 Business Overview
  • 2.20.2 Oncology Small Molecule Drugs Type and Applications
    • 2.20.2.1 Product A
    • 2.20.2.2 Product B
  • 2.20.3 AstraZeneca Oncology Small Molecule Drugs Revenue, Gross Margin and Market Share (2017-2018)
• 2.21 Gilead Sciences
  • 2.21.1 Business Overview
  • 2.21.2 Oncology Small Molecule Drugs Type and Applications
    • 2.21.2.1 Product A
    • 2.21.2.2 Product B
  • 2.21.3 Gilead Sciences Oncology Small Molecule Drugs Revenue, Gross Margin and Market Share (2017-2018)
• 2.22 Exelixis
  • 2.22.1 Business Overview
  • 2.22.2 Oncology Small Molecule Drugs Type and Applications
    • 2.22.2.1 Product A
    • 2.22.2.2 Product B
  • 2.22.3 Exelixis Oncology Small Molecule Drugs Revenue, Gross Margin and Market Share (2017-2018)

3 Global Oncology Small Molecule Drugs Market Competition, by Players

• 3.1 Global Oncology Small Molecule Drugs Revenue and Share by Players (2014-2019)
• 3.2 Market Concentration Rate
  • 3.2.1 Top 5 Oncology Small Molecule Drugs Players Market Share
  • 3.2.2 Top 10 Oncology Small Molecule Drugs Players Market Share
• 3.3 Market Competition Trend

4 Global Oncology Small Molecule Drugs Market Size by Regions

• 4.1 Global Oncology Small Molecule Drugs Revenue and Market Share by Regions
• 4.2 North America Oncology Small Molecule Drugs Revenue and Growth Rate (2014-2019)
• 4.3 Europe Oncology Small Molecule Drugs Revenue and Growth Rate (2014-2019)
• 4.4 Asia-Pacific Oncology Small Molecule Drugs Revenue and Growth Rate (2014-2019)
• 4.5 South America Oncology Small Molecule Drugs Revenue and Growth Rate (2014-2019)
• 4.6 Middle East and Africa Oncology Small Molecule Drugs Revenue and Growth Rate (2014-2019)

5 North America Oncology Small Molecule Drugs Revenue by Countries

• 5.1 North America Oncology Small Molecule Drugs Revenue by Countries (2014-2019)
• 5.2 USA Oncology Small Molecule Drugs Revenue and Growth Rate (2014-2019)
• 5.3 Canada Oncology Small Molecule Drugs Revenue and Growth Rate (2014-2019)
• 5.4 Mexico Oncology Small Molecule Drugs Revenue and Growth Rate (2014-2019)

6 Europe Oncology Small Molecule Drugs Revenue by Countries

• 6.1 Europe Oncology Small Molecule Drugs Revenue by Countries (2014-2019)
• 6.2 Germany Oncology Small Molecule Drugs Revenue and Growth Rate (2014-2019)
• 6.3 UK Oncology Small Molecule Drugs Revenue and Growth Rate (2014-2019)
• 6.4 France Oncology Small Molecule Drugs Revenue and Growth Rate (2014-2019)
• 6.5 Russia Oncology Small Molecule Drugs Revenue and Growth Rate (2014-2019)
• 6.6 Italy Oncology Small Molecule Drugs Revenue and Growth Rate (2014-2019)

7 Asia-Pacific Oncology Small Molecule Drugs Revenue by Countries

• 7.1 Asia-Pacific Oncology Small Molecule Drugs Revenue by Countries (2014-2019)
• 7.2 China Oncology Small Molecule Drugs Revenue and Growth Rate (2014-2019)
• 7.3 Japan Oncology Small Molecule Drugs Revenue and Growth Rate (2014-2019)
• 7.4 Korea Oncology Small Molecule Drugs Revenue and Growth Rate (2014-2019)
• 7.5 India Oncology Small Molecule Drugs Revenue and Growth Rate (2014-2019)
• 7.6 Southeast Asia Oncology Small Molecule Drugs Revenue and Growth Rate (2014-2019)

8 South America Oncology Small Molecule Drugs Revenue by Countries

• 8.1 South America Oncology Small Molecule Drugs Revenue by Countries (2014-2019)
• 8.2 Brazil Oncology Small Molecule Drugs Revenue and Growth Rate (2014-2019)
• 8.3 Argentina Oncology Small Molecule Drugs Revenue and Growth Rate (2014-2019)
• 8.4 Colombia Oncology Small Molecule Drugs Revenue and Growth Rate (2014-2019)

9 Middle East and Africa Revenue Oncology Small Molecule Drugs by Countries

• 9.1 Middle East and Africa Oncology Small Molecule Drugs Revenue by Countries (2014-2019)
• 9.2 Saudi Arabia Oncology Small Molecule Drugs Revenue and Growth Rate (2014-2019)
• 9.3 UAE Oncology Small Molecule Drugs Revenue and Growth Rate (2014-2019)
• 9.4 Egypt Oncology Small Molecule Drugs Revenue and Growth Rate (2014-2019)
• 9.5 Nigeria Oncology Small Molecule Drugs Revenue and Growth Rate (2014-2019)
• 9.6 South Africa Oncology Small Molecule Drugs Revenue and Growth Rate (2014-2019)

10 Global Oncology Small Molecule Drugs Market Segment by Type

• 10.1 Global Oncology Small Molecule Drugs Revenue and Market Share by Type (2014-2019)
• 10.2 Global Oncology Small Molecule Drugs Market Forecast by Type (2019-2024)
• 10.3 Chemotherapy Drugs Revenue Growth Rate (2014-2024)
• 10.4 Immunomodulating Drugs Revenue Growth Rate (2014-2024)
• 10.5 Targeted Therapy Drugs Revenue Growth Rate (2014-2024)
• 10.6 Hormonal Therapy Revenue Growth Rate (2014-2024)
• 10.7 Other Revenue Growth Rate (2014-2024)

11 Global Oncology Small Molecule Drugs Market Segment by Application

• 11.1 Global Oncology Small Molecule Drugs Revenue Market Share by Application (2014-2019)
• 11.2 Oncology Small Molecule Drugs Market Forecast by Application (2019-2024)
• 11.3 Blood Cancer Revenue Growth (2014-2019)
• 11.4 Breast Cancer Revenue Growth (2014-2019)
• 11.5 Gastrointestinal Cancer Revenue Growth (2014-2019)
• 11.6 Prostate Cancer Revenue Growth (2014-2019)
• 11.7 Lung Cancer Revenue Growth (2014-2019)
• 11.8 Other Revenue Growth (2014-2019)

12 Global Oncology Small Molecule Drugs Market Size Forecast (2019-2024)

• 12.1 Global Oncology Small Molecule Drugs Market Size Forecast (2019-2024)
• 12.2 Global Oncology Small Molecule Drugs Market Forecast by Regions (2019-2024)
• 12.3 North America Oncology Small Molecule Drugs Revenue Market Forecast (2019-2024)
• 12.4 Europe Oncology Small Molecule Drugs Revenue Market Forecast (2019-2024)
• 12.5 Asia-Pacific Oncology Small Molecule Drugs Revenue Market Forecast (2019-2024)
• 12.6 South America Oncology Small Molecule Drugs Revenue Market Forecast (2019-2024)
• 12.7 Middle East and Africa Oncology Small Molecule Drugs Revenue Market Forecast (2019-2024)

13 Research Findings and Conclusion

14 Appendix

• 14.1 Methodology